Clene Current Deferred Revenue from 2010 to 2026
| CLNN Stock | USD 4.21 0.02 0.47% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 3.1 M | Current Value 3.2 M | Quarterly Volatility 2.9 M |
Check Clene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clene's main balance sheet or income statement drivers, such as Other Operating Expenses of 29.1 M, Total Operating Expenses of 28.9 M or Depreciation And Amortization of 1.2 M, as well as many indicators such as Price To Sales Ratio of 118, Dividend Yield of 0.0 or Days Sales Outstanding of 456. Clene financial statements analysis is a perfect complement when working with Clene Valuation or Volatility modules.
Clene | Current Deferred Revenue | Build AI portfolio with Clene Stock |
Evaluating Clene's Current Deferred Revenue across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Clene Inc's fundamental strength.
Latest Clene's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Clene Inc over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Clene's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clene's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Clene Current Deferred Revenue Regression Statistics
| Arithmetic Mean | (1,613,133) | |
| Coefficient Of Variation | (179.26) | |
| Mean Deviation | 2,628,918 | |
| Median | (4,096,000) | |
| Standard Deviation | 2,891,636 | |
| Sample Variance | 8.4T | |
| Range | 7.3M | |
| R-Value | 0.91 | |
| Mean Square Error | 1.6T | |
| R-Squared | 0.82 | |
| Slope | 518,503 | |
| Total Sum of Squares | 133.8T |
Clene Current Deferred Revenue History
About Clene Financial Statements
Clene investors utilize fundamental indicators, such as Current Deferred Revenue, to predict how Clene Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 3.1 M | 3.2 M |
Pair Trading with Clene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clene will appreciate offsetting losses from the drop in the long position's value.Moving together with Clene Stock
Moving against Clene Stock
| 0.85 | DRTS | Alpha Tau Medical | PairCorr |
| 0.72 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.72 | DSGN | Design Therapeutics | PairCorr |
| 0.71 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.69 | VERA | Vera Therapeutics Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Clene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clene Inc to buy it.
The correlation of Clene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clene Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Clene Correlation against competitors. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Will Biotechnology sector continue expanding? Could Clene diversify its offerings? Factors like these will boost the valuation of Clene. Projected growth potential of Clene fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Clene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.614 | Earnings Share (3.44) | Revenue Per Share | Quarterly Revenue Growth (0.83) | Return On Assets |
Understanding Clene Inc requires distinguishing between market price and book value, where the latter reflects Clene's accounting equity. The concept of intrinsic value - what Clene's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Clene's price substantially above or below its fundamental value.
It's important to distinguish between Clene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Clene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Clene's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.